Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Indofood CBP Sukses Makmur Tbk. (ICBP) vs Organon Pharma Indonesia Tbk. (SCPI)

Indofood CBP Sukses Makmur Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Indofood CBP Sukses Makmur Tbk. dan Organon Pharma Indonesia Tbk.: Indofood CBP Sukses Makmur Tbk. diperdagangkan di Rp7.125 (kapitalisasi pasar 83,67 T, volume 24 jam 2,21 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indofood CBP Sukses Makmur Tbk. jauh lebih besar — sekitar 801,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

ICBPSCPI
Kapitalisasi Pasar
83,67 T104,4 M
Volume
2,21 jt
Lot
22,05 rb
Perputaran
15,7 M
Harga Rata-rata
7.121,29
Nilai Transaksi
15,7 M
Harga Ekuilibrium Indikatif
7.125
Volume Ekuilibrium Indikatif
1,3 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ICBP
Lihat detail
SCPI
Lihat detail

Tentang Indofood CBP Sukses Makmur Tbk.

PT Indofood CBP Sukses Makmur (the company) was established on Sept 2, 2009, based on Notarial Deed No.25 of Herdimansyah Chaidirsyah, S.H. The Company’s Articles of Association was amended several times, the latest of which was covered in the Notarial Deed no.28 of Benny Kristianto dated Jun 10, 2010, among other, for the amendments in the company's whole articles of Association to comply with the requirements of the Capital Market and Financial Institutions Supervisory Agency.The Company was a spin-off of the noodle division and food ingredient division of PT Indofood Sukses Makmur Tbk, the shareholder of the Company, and started to carry out the related business operations on Oct 1, 2009.

Selengkapnya di halaman ICBP

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI